Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Ismael Macias Declara"'
Autor:
Paula Jimenez-Fonseca, Victoria Foy, Sophie Raby, Alberto Carmona-Bayonas, Lola Macía-Rivas, Virginia Arrazubi, Diego Cacho Lavin, Raquel Hernandez San Gil, Ana Custodio, Juana María Cano, Ana Fernández Montes, Oriol Mirallas, Ismael Macias Declara, Rosario Vidal Tocino, Laura Visa, María Luisa Limón, Paola Pimentel, Nieves Martínez Lago, Tamara Sauri, Marta Martín Richard, Monserrat Mangas, Mireia Gil Raga, Aitana Calvo, Pablo Reguera, Mónica Granja, Alfonso Martín Carnicero, Carolina Hernández Pérez, Paula Cerdá, Lucía Gomez Gonzalez, Francisco Garcia Navalon, Vilma Pacheco Barcia, David Gutierrez Abad, Maribel Ruiz Martín, Jamie Weaver, Wasat Mansoor, Javier Gallego
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 15 (2023)
Background: Trastuzumab and chemotherapy is the standard first-line treatment in human epidermal growth factor receptor 2 (HER2)-positive advanced gastro-oesophageal cancer. The objective was to develop a predictive model for overall survival (OS) an
Externí odkaz:
https://doaj.org/article/cf85aa4387664f46bdb19d331cc85d54
Autor:
Paula Jimenez-Fonseca, Alberto Carmona-Bayonas, Alba Martinez-Torron, Maria Alsina, Ana Custodio, Olbia Serra, Diego Cacho Lavin, María Luisa Limón, Tamara Sauri, Flora López, Laura Visa, Mónica Granja, Nieves Martínez Lago, Virginia Arrazubi, Rosario Vidal Tocino, Raquel Hernandez, Gema Aguado, Juana María Cano, Alfonso Martín Carnicero, Monserrat Mangas, Paola Pimentel, Ana Fernández Montes, Ismael Macias Declara, Federico Longo, Avinash Ramchandani, Marta Martín Richard, Alicia Hurtado, Aitor Azkarate, Carolina Hernández Pérez, Raquel Serrano, Javier Gallego
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Background: Trastuzumab combined with cisplatin and fluoropyrimidines, either capecitabine or 5-fluorouracile (XP/FP), is the standard first-line treatment for advanced, HER2-positive, gastric cancer patients based on the ToGA trial. Despite the lack
Externí odkaz:
https://doaj.org/article/461c7ab35c804b44a5bffb5634234fe5
Autor:
Miguel Angel Seguí-Palmer, Clara Ejarque, Sandra Soriano, Laia Vilà, Pablo Villace Gallego, Enrique Gallardo Diaz, Ismael Macias Declara, Paula Ribera Fernandez, Laura Medina, Teresa Bonfill, Julia Giner Joaquin, Pablo Andreu, Marta Osorio Rodríguez
Publikováno v:
Journal of Clinical Oncology. 39:e24020-e24020
e24020 Background: Elderly patients (pts) diagnosed with cancer may present frailty conditions at baseline that could have a direct impact on tolerance and toxicity of oncological treatments (ttm). Comprehensive geriatric assessment (CGA) is consider
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7f7bde93531431e0387b579c685da698
https://doi.org/10.1200/jco.2021.39.15_suppl.e24020
https://doi.org/10.1200/jco.2021.39.15_suppl.e24020
Autor:
Vicente Alonso, Carlos Fernández-Martos, B. Navalpotro, Xabier García-Albéniz, Ismael Macias Declara, Daniel Acosta, J. Hernando, A. Garcia-Alvarez, Joan Maurel, Javier Gallego Plazas, Ruth Vera, Marcos Melian, Marc Diez, Ferran Losa, Maria Carmen Riesco Martinez, Begoña Graña Suárez, Jaume Capdevila
Publikováno v:
Web of Science
JOURNAL OF CLINICAL ONCOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
JOURNAL OF CLINICAL ONCOLOGY
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
TPS4122 Background: In clinical stages II and III (cT3-4 and/or N+), preoperative chemoradiotherapy (CRT) or short-course radiation followed by total mesorectal escision (TME) have been the standard of care for the last 15 years. Induction chemothera
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1023746e837d98b79d0eb333449eb123
https://doi.org/10.1200/jco.2020.38.15_suppl.tps4122
https://doi.org/10.1200/jco.2020.38.15_suppl.tps4122
Autor:
Isabel Echavarria, Monserrat Mangas, Ana Custodio, Paula Cerdá, Federico Longo, Javier Gallego Plazas, Marcelo Garrido, Eduardo Castanon, Laura Visa, Ismael Macias Declara, Elvira Buxó, Antonio Viudez, Raquel Hernández, Asunción Díaz-Serrano, Rodrigo Sánchez Bayona, Alberto Rodríguez Palomo, Maria Pilar Felices Lobera, Juana María Cano, María Luisa Limón, Carlos López, Maria Alsina, Maria Luisa Sánchez Lorenzo, T. García, Avinash Ramchandani, Carlos Gomez-Martin, Alberto Carmona-Bayonas, Alicia Hurtado Nuño, R. Serrano, Aitor Azkarate, Paula Jiménez-Fonseca, Paola Pimentel, Renata Álvarez Llosa
Publikováno v:
Gastric Cancer
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
r-FISABIO: Repositorio Institucional de Producción Científica
Fundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO)
r-FISABIO. Repositorio Institucional de Producción Científica
instname
Trastuzumab significantly improves overall survival (OS) when added to cisplatin and fluoropyrimidine as a treatment for HER2-positive advanced gastric cancers (AGC). The aim of this study was to evaluate the impact of the gradual implementation of H
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d4d58629c33ab91400d11870ab4fcf1
https://pubmed.ncbi.nlm.nih.gov/27599830
https://pubmed.ncbi.nlm.nih.gov/27599830
Autor:
Julia Giner Joaquin, Elsa Dalmau Portulas, Paula Ribera Fernandez, Eugeni Saigi Grau, Clara Martinez Vila, Jose Manuel Cabrera Romero, Helena Oliveres Montero De Novoa, Marta Ferrer Cardona, Juan Carlos Pardo Ruiz, Y. García, Ismael Macias Declara, Maria Marin Alcala
Publikováno v:
Journal of Thoracic Oncology. 12:S1379-S1380
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1eaf3eff832b40d9e35cc582b58166d
https://doi.org/10.1016/j.jtho.2016.11.1954
https://doi.org/10.1016/j.jtho.2016.11.1954
Autor:
Vicente Alonso, Javier Gallego Plazas, Ruth Vera, Maria Jose Safont, Jorge Adeva Alfonso, Mercedes Salgado Fernández, Ismael Macias Declara, Helena Asensio-Martínez, Carles Pericay, Carmen Guillén-Ponce
Publikováno v:
Journal of Clinical Oncology. 36:e15690-e15690
e15690Background: Standart treatment in locally advanced rectal cancer (LARC) is neoadjuvant chemoradiotherapy (NCRT). Of all treated patients (pts), less than 20% will achieve pCR. These pts have ...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::91c91b4cc021df2bca1948a94bf1cd44
https://doi.org/10.1200/jco.2018.36.15_suppl.e15690
https://doi.org/10.1200/jco.2018.36.15_suppl.e15690
Autor:
Ismael Macias Declara, Mercedes Salgado Fernández, Maria Marin Alcala, Luis Cirera, Leticia Iglesias Rey, Julen Fernández Plana, Carles Pericay, Ana Montes, Lucía Gómez González, María Ballester Espinosa, Helena Asensio-Martínez, Javier Gallego Plazas, H. Oliveres, J. A. García-Gómez
Publikováno v:
Journal of Clinical Oncology. 36:e18731-e18731
e18731Background: Colorectal cancer is a global problem due the incidence and prevalence. Clinical trials do not represent treatment of real life population effectiveness , so real world data trial...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8490c9ceb0754a6b9ed48cb975f781e4
https://doi.org/10.1200/jco.2018.36.15_suppl.e18731
https://doi.org/10.1200/jco.2018.36.15_suppl.e18731
Autor:
Estela Pineda Losada, Carmen Castañon Lopez, Pilar Escudero, Vicente Alonso, Gemma Soler Gonzalez, Monica Guillot Morales, Jaime Feliu, Alberto Carmona, Jorge Aparicio, Brenzo Martinez-Amores, Ana Ruíz Casado, Gemma Soler, Antonio Cubillo, Cristina Llorca, Antonieta Salud, Ismael Macias Declara
Publikováno v:
Journal of Clinical Oncology. 36:TPS3618-TPS3618
TPS3618Background: Approximately 60% of colorectal cancer (CRC) patients are ≥ 70 years, of whom 50-60% already have metastasis at the time of diagnosis. Available data indicate that elderly patien...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7a590d59aaec90bfe63895db03c6ea27
https://doi.org/10.1200/jco.2018.36.15_suppl.tps3618
https://doi.org/10.1200/jco.2018.36.15_suppl.tps3618
Autor:
Salvador Navarro, Eugeni Saigí, Maria Marin Alcala, Laia Vilà, Ismael Macias Declara, Paula Ribera Fernandez, Sandra Montmany, Clara MartÃnez Vila, Pere Rebasa, Alexis Luna, Antoni Malet Munte, H. Oliveres, Ruth Orellana, Carles Pericay
Publikováno v:
Journal of Clinical Oncology. 36:e16094-e16094
e16094Background: Currently, ECF/ECX is the standard of care for peri-operative oesophagogastric adenocarcinoma (OGA), considering MAGIC trial even though the outcome still remains unsatisfactory w...
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::768a55a54f0ba514b164a0586c1bb32d
https://doi.org/10.1200/jco.2018.36.15_suppl.e16094
https://doi.org/10.1200/jco.2018.36.15_suppl.e16094